EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer’s disease

Jonas Rybnicek iD, Yuxiao Chen, Milos Milic, Earvin S Tio iD, JoAnne McLaurin, Timothy J Hohman iD, Philip L De Jager iD, Julie A Schneider iD, Yanling Wang iD, David A Bennett, Shreejoy Tripathy, Daniel Felsky iD und 1 weitere

Translational Psychiatry · 2024

DOI: 10.1038/s41398-024-02785-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Psychiatry, 2024. Verfasst von Jonas Rybnicek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Nicotinic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Gouvernement du Canada | Canadian Institutes of Health Research, Gouvernement du Canada | Instituts de Recherche en Santé du Canada | Institute of Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Changes in high-affinity nicotinic acetylcholine receptors are intricately connected to neuropathology in Alzheimer’s Disease (AD). Protective and cognitive-enhancing roles for the nicotinic α5 subunit have been identified, but this gene has not been closely examined in the context of human aging and dementia. Therefore, we investigate the nicotinic α5 gene CHRNA5 and the impact of relevant single nucleotide polymorphisms (SNPs) in prefrontal cortex from 922 individuals with matched genotypic and post-mortem RNA sequencing in the Religious Orders Study and Memory and Aging Project (ROS/MAP). We find that a genotype robustly linked to increased expression of CHRNA5 (rs1979905A2) predicts significantly reduced cortical β-amyloid load. Intriguingly, co-expression analysis suggests CHRNA5 has a distinct cellular expression profile compared to other nicotinic receptor genes. Consistent with this prediction, single nucleus RNA sequencing from 22 individuals reveals CHRNA5 expression is disproportionately elevated in chandelier neurons, a distinct subtype of inhibitory neuron known for its role in excitatory/inhibitory (E/I) balance. We show that chandelier neurons are enriched in amyloid-binding proteins compared to basket cells, the other major subtype of PVALB-positive interneurons. Consistent with the hypothesis that nicotinic receptors in chandelier cells normally protect against β-amyloid, cell-type proportion analysis from 549 individuals reveals these neurons show amyloid-associated vulnerability only in individuals with impaired function/trafficking of nicotinic α5-containing receptors due to homozygosity of the missense CHRNA5 SNP (rs16969968A2). Taken together, these findings suggest that CHRNA5 and its nicotinic α5 subunit exert a neuroprotective role in aging and Alzheimer’s disease centered on chandelier interneurons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseReceptors, NicotinicHumansNicotineNeuronsAmyloid beta-PeptidesAgingNerve Tissue Proteins

Substanzen

Receptors, NicotinicNicotineAmyloid beta-PeptidesCHRNA5 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Physiology, University of Toronto, Toronto, ON, Canada.
  • Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Biological Sciences, Sunnybrook Research Institute, Toronto, ON, Canada.
  • Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Center for Translational & Computational Neuroimmunology, Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY,…

ORCID-Profile: Jonas Rybnicek, Earvin S Tio, Timothy J Hohman, Philip L De Jager, Julie A Schneider, Yanling Wang, Daniel Felsky, Evelyn K Lambe

Förderung

  • NIA NIH HHS
  • Gouvernement du Canada | Canadian Institutes of Health Research
  • Gouvernement du Canada | Instituts de Recherche en Santé du Canada | Institute of Aging
  • Canada Research Chairs
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging
  • Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
  • Krembil Foundation, Koerner Family Foundation, and the CAMH Discovery Fund

Zitieren

APA

Rybnicek, J., Chen, Y., Milic, M., Tio, E. S., McLaurin, J., Hohman, T. J., De Jager, P. L., Schneider, J. A., Wang, Y., Bennett, D. A., Tripathy, S., Felsky, D., & Lambe, E. K. (2024). CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer’s disease. Translational Psychiatry. https://doi.org/10.1038/s41398-024-02785-3

Vancouver

Rybnicek J, Chen Y, Milic M, Tio ES, McLaurin J, Hohman TJ, et al. CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer’s disease. Translational Psychiatry. 2024. doi:10.1038/s41398-024-02785-3

BibTeX
@article{Rybnicek2024,
  author = {Rybnicek, Jonas and Chen, Yuxiao and Milic, Milos and Tio, Earvin S and McLaurin, JoAnne and Hohman, Timothy J and De Jager, Philip L and Schneider, Julie A and Wang, Yanling and Bennett, David A and Tripathy, Shreejoy and Felsky, Daniel and Lambe, Evelyn K},
  title = {CHRNA5 links chandelier cells to severity of amyloid pathology in aging and Alzheimer’s disease},
  journal = {Translational Psychiatry},
  year = {2024},
  doi = {10.1038/s41398-024-02785-3}
}
Kostenlos starten →